Time to Reconsider Cantel Medical Corp. (CMD) After Achieving All Time High?

January 19, 2018 - By Ellis Scott

The stock of Cantel Medical Corp. (NYSE:CMD) reached all time high today, Jan, 19 and still has $117.38 target or 4.00 % above today’s $112.87 share price. This indicates more upside for the $4.73 billion company. This technical setup was reported by Barchart.com. If the $117.38 PT is reached, the company will be worth $189.32M more.
Trading stocks at an all time highs is usually a winning strategy. An all time high points to a stock which has the most positive fundamentals ever. Even thought the pullback rate is high, if correct risk management is utilized, investors can trade very well such events.

The stock increased 1.59% or $1.77 during the last trading session, reaching $112.87. About 77,304 shares traded. Cantel Medical Corp. (NYSE:CMD) has risen 11.32% since January 19, 2017 and is uptrending. It has underperformed by 5.38% the S&P500.

Analysts await Cantel Medical Corp. (NYSE:CMD) to report earnings on March, 8. They expect $0.58 earnings per share, up 11.54 % or $0.06 from last year’s $0.52 per share. CMD’s profit will be $24.32 million for 48.65 P/E if the $0.58 EPS becomes a reality. After $0.57 actual earnings per share reported by Cantel Medical Corp. for the previous quarter, Wall Street now forecasts 1.75 % EPS growth.

Cantel Medical Corp. (NYSE:CMD) Ratings Coverage

Among 2 analysts covering Cantel Medical (NYSE:CMD), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Cantel Medical had 2 analyst reports since March 17, 2017 according to SRatingsIntel. The rating was downgraded by Benchmark on Friday, June 9 to “Hold”. Raymond James initiated Cantel Medical Corp. (NYSE:CMD) on Friday, March 17 with “Mkt Perform” rating.

More notable recent Cantel Medical Corp. (NYSE:CMD) news were published by: Fool.com which released: “Cantel Medical Corp. Gives the Bottom Line a Boost” on June 08, 2017, also Fool.com with their article: “Cantel Medical (CMD) Q1 2018 Earnings Conference Call Transcript” published on December 08, 2017, Prnewswire.com published: “Cantel Medical to Acquire BHT Group in Germany” on July 31, 2017. More interesting news about Cantel Medical Corp. (NYSE:CMD) were released by: Nasdaq.com and their article: “Cantel Medical Corp. (CMD) Ex-Dividend Date Scheduled for January 16, 2018” published on January 12, 2018 as well as Fool.com‘s news article titled: “Cantel Medical Corp. Posts Double-Digit Growth Across the Board” with publication date: March 13, 2017.

Cantel Medical Corp. provides infection prevention services and products for the healthcare market worldwide. The company has market cap of $4.73 billion. The firm operates through four divisions: Endoscopy, Water Purification and Filtration, Healthcare Disposables, and Dialysis. It has a 62.39 P/E ratio. The Endoscopy segment offers automated endoscope reprocessing systems; detergents; leak testing and manual cleaning products; storage cabinets; transport systems; mobile medical carts; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid and flexible endoscopes, and other instrumentation; cleaning and disinfecting reusable components used in gastrointestinal endoscopy procedures; and technical maintenance services.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.